Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2014-09-11 05:14:39 UTC |
---|
Update Date | 2016-11-09 01:09:12 UTC |
---|
Accession Number | CHEM003705 |
---|
Identification |
---|
Common Name | Methyltestosterone |
---|
Class | Small Molecule |
---|
Description | A synthetic anabolic steroid used for treating men with testosterone deficiency or similar androgen replacement therapies. Also, has antineoplastic properties and so has been used secondarily in women with advanced breast cancer. Methyltestosterone is a schedule III drug in the US. |
---|
Contaminant Sources | - HMDB Contaminants - Urine
- STOFF IDENT Compounds
- T3DB toxins
- ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | - Anabolic Agent
- Antineoplastic Agent, Hormonal
- Drug
- Ester
- Hormone Replacement Agent
- Metabolite
- Organic Compound
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
17(alpha)-Methyl-Delta(4)-androsten-17(beta)-ol-3-one | ChEBI | 17-beta-Hydroxy-17-methylandrost-4-en-3-one | ChEBI | 17-Methyltestosterone | ChEBI | 17alpha-Methyl-3-oxo-4-androsten-17beta-ol | ChEBI | 17alpha-Methyl-Delta(4)-androsten-17beta-ol-3-one | ChEBI | 17alpha-Methyltestosterone | ChEBI | 17beta-Hydroxy-17-methylandrost-4-en-3-one | ChEBI | 4-Androstene-17alpha-methyl-17beta-ol-3-one | ChEBI | Android | ChEBI | Methyltestosteronum | ChEBI | Metiltestosterona | ChEBI | NSC-9701 | ChEBI | Testred | ChEBI | Virilon | ChEBI | 17(a)-Methyl-delta(4)-androsten-17(b)-ol-3-one | Generator | 17(Α)-methyl-δ(4)-androsten-17(β)-ol-3-one | Generator | 17-b-Hydroxy-17-methylandrost-4-en-3-one | Generator | 17-Β-hydroxy-17-methylandrost-4-en-3-one | Generator | 17a-Methyl-3-oxo-4-androsten-17b-ol | Generator | 17Α-methyl-3-oxo-4-androsten-17β-ol | Generator | 17a-Methyl-delta(4)-androsten-17b-ol-3-one | Generator | 17Α-methyl-δ(4)-androsten-17β-ol-3-one | Generator | 17a-Methyltestosterone | Generator | 17Α-methyltestosterone | Generator | 17b-Hydroxy-17-methylandrost-4-en-3-one | Generator | 17Β-hydroxy-17-methylandrost-4-en-3-one | Generator | 4-Androstene-17a-methyl-17b-ol-3-one | Generator | 4-Androstene-17α-methyl-17β-ol-3-one | Generator | 17(a)-Methyl-δ(4)-androsten-17(b)-ol-3-one | HMDB | 17a-Methyl-δ(4)-androsten-17b-ol-3-one | HMDB | 17alpha-Methyl-delta-androsten-17beta-ol-3-one | HMDB | 17 Epimethyltestosterone | HMDB | 17 beta Methyltestosterone | HMDB | 17alpha Methyltestosterone | HMDB | Mesteron | HMDB | 17 beta-Methyltestosterone | HMDB | 17-Epimethyltestosterone | HMDB | 17beta Hydroxy 17 methyl 4 androsten 3 one | HMDB | 17beta Methyltestosterone | HMDB | 17beta-Hydroxy-17-methyl-4-androsten-3-one | HMDB | Android-25 | HMDB | Global pharmaceutical brand OF methyltestosterone | HMDB | ICN brand 1 OF methyltestosterone | HMDB | ICN brand 2 OF methyltestosterone | HMDB | 17 alpha Methyltestosterone | HMDB | 17-alpha-Methyltestosterone | HMDB | 17alpha-Methyl-testosterone | HMDB | Android 25 | HMDB | Android 5 | HMDB | Android-5 | HMDB | Metandren | HMDB | Star brand OF methyltestosterone | HMDB | 17 beta Hydroxy 17 methyl 4 androsten 3 one | HMDB | 17 beta-Hydroxy-17-methyl-4-androsten-3-one | HMDB | 17alpha Methyl testosterone | HMDB | 17beta-Methyltestosterone | HMDB | Android 10 | HMDB | Android-10 | HMDB | Mesterone | HMDB | Methitest | HMDB | Oreton | HMDB | Schering brand OF methyltestosterone | HMDB | Testoviron | HMDB | Methyltestosterone | MeSH | Android (methyltestoterone) | MeSH |
|
---|
Chemical Formula | C20H30O2 |
---|
Average Molecular Mass | 302.451 g/mol |
---|
Monoisotopic Mass | 302.225 g/mol |
---|
CAS Registry Number | 58-18-4 |
---|
IUPAC Name | (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
Traditional Name | (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
SMILES | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h12,15-17,22H,4-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1 |
---|
InChI Key | GCKMFJBGXUYNAG-HLXURNFRSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Androstane steroids |
---|
Direct Parent | Androgens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Androgen-skeleton
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- Hydroxysteroid
- Oxosteroid
- 17-hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Tertiary alcohol
- Cyclic alcohol
- Ketone
- Cyclic ketone
- Organooxygen compound
- Alcohol
- Carbonyl group
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
|
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 163°C | Boiling Point | Not Available | Solubility | 33.9 mg/L (at 25°C) |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-00dr-0290000000-371930adb441ed456954 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (1 TMS) - 70eV, Positive | splash10-0aba-1219000000-f0c8c14754130edea3b1 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - , positive | splash10-0udi-1329000000-c8db8c2a5d8403c476e1 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 45V, Positive | splash10-052b-6910000000-9318ec38a89b29c5640a | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 30V, Positive | splash10-0udj-5869000000-d793d0f4b0e7a48b07f6 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 30V, Positive | splash10-0f9i-0951000000-9748785b49ecb149e24a | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-0udi-0139000000-8aa4cb730b0ff1f71ea4 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 35V, Positive | splash10-0k92-4933000000-7acf74ca59be288f2614 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-0udi-0009000000-ae79c4e9732d83ed38d9 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 50V, Positive | splash10-05gi-0900000000-d1cbdda02301f6a94288 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-00ea-0910000000-3f3f55e272ef7299acdf | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 90V, Positive | splash10-054k-9400000000-bf00a69bc23c369a2331 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 15V, Positive | splash10-0udi-0009000000-d366eb35472b9a72d3ba | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 75V, Positive | splash10-052b-9600000000-ff447f9aa855eb5ec701 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 60V, Positive | splash10-052b-8900000000-f4aa99526d10876e16d4 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 50V, Positive | splash10-05gi-0900000000-988e08204d56c840af72 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-00ea-0910000000-4231a8d617491b200562 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 30V, Positive | splash10-0f9i-0951000000-ef720a8b9da17a0ec5a3 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-0029000000-5462129b9677fa78ae8a | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0udi-0059000000-989aea076743d8116d13 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-052u-0190000000-c80d428af7a5f339800c | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-0009000000-16d58525184e918518fa | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0udi-0009000000-16d58525184e918518fa | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0udi-0069000000-9a3f52e7a44897ce9e5e | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0f79-0195000000-6ddd9c839c0b3b88c691 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0f79-0391000000-2fe2bafacddeeeb1f5f5 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0gbc-3890000000-9798d48acbfa04cc8bf0 | Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-006x-7921000000-0e8f2747a2f3c8166048 | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | The methyl group aids to increase oral bioavailability. |
---|
Mechanism of Toxicity | The effects of testosterone in humans and other vertebrates occur by way of two main mechanisms: by activation of the androgen receptor (directly or as DHT), and by conversion to estradiol and activation of certain estrogen receptors. Free testosterone (T) is transported into the cytoplasm of target tissue cells, where it can bind to the androgen receptor, or can be reduced to 5α-dihydrotestosterone (DHT) by the cytoplasmic enzyme 5α-reductase. DHT binds to the same androgen receptor even more strongly than T, so that its androgenic potency is about 2.5 times that of T. The T-receptor or DHT-receptor complex undergoes a structural change that allows it to move into the cell nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects. |
---|
Metabolism | Hepatic.
Testosterone is metabolized to 17-keto steroids through two different pathways. The major active metabolites are estradiol and dihydrotestosterone (DHT).
Route of Elimination: 90% urine / 10% feces
Half Life: 6-8 hours |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | Methyltestosterone is an anabolic steroid hormone used to treat men with a testosterone deficiency. It is also used in women to treat breast cancer, breast pain, swelling due to pregnancy, and with the addition of estrogen it can treat symptoms of menopause. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Side effects include amnesia, anxiety, discolored hair, dizziness, dry skin, hirsutism, hostility, impaired urination, paresthesia, penis disorder, peripheral edema, sweating, and vasodilation. |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB06710 |
---|
HMDB ID | HMDB0015655 |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Methyltestosterone |
---|
Chemspider ID | 5788 |
---|
ChEBI ID | 27436 |
---|
PubChem Compound ID | 6010 |
---|
Kegg Compound ID | C07198 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | |
---|